A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions

[1] Neumann FJ(2019)2018 ESC/EACTS guidelines on myocardial revascularization Eur Heart J 40 87-165

[2] Sousa-Uva M(2012)A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J Am Coll Cardiol 60 2473-2480

[3] Ahlsson A(2013)Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study are lesions clinically stable from 12 to 36 months EuroIntervention 9 620-628

[4] Alfonso F(2010)Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study Heart 96 1291-1296

[5] Banning AP(2003)Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation J Am Coll Cardiol 42 1415-1420

[6] Benedetto U(2018)Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Lancet 392 849-856

[7] Byrne RA(2018)Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial JACC Cardiovasc Interv 11 2381-2392

[8] Collet JP(2019)Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute Clin Res Cardiol 108 234-243

[9] Falk V(2019)12-month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm Int J Card Imaging 35 579-586

[10] Head SJ(2019)Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels J Cardiol 73 151-155

[1] Neumann FJ(2019)2018 ESC/EACTS guidelines on myocardial revascularization Eur Heart J 40 87-165

[2] Sousa-Uva M(2012)A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J Am Coll Cardiol 60 2473-2480

[3] Ahlsson A(2013)Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study are lesions clinically stable from 12 to 36 months EuroIntervention 9 620-628

[4] Alfonso F(2010)Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study Heart 96 1291-1296

[5] Banning AP(2003)Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation J Am Coll Cardiol 42 1415-1420

[6] Benedetto U(2018)Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Lancet 392 849-856

[7] Byrne RA(2018)Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial JACC Cardiovasc Interv 11 2381-2392

[8] Collet JP(2019)Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute Clin Res Cardiol 108 234-243

[9] Falk V(2019)12-month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm Int J Card Imaging 35 579-586

[10] Head SJ(2019)Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels J Cardiol 73 151-155